Log in or Sign up for Free to view tailored content for your specialty!
Intervention News
Heart failure outcomes after interatrial shunt implant vary by ejection fraction
ATLANTA — Transcatheter implant of an inter-atrial shunt had drastically different results depending on ejection fraction in patients with HF, a speaker reported at the American College of Cardiology Scientific Session.
ACC to showcase ‘exceptional’ science, mark 75 years at upcoming scientific session
The 2024 American College of Cardiology Scientific Session will be held live in Atlanta from April 6 to 8 and virtually, with 43 late-breaking trials and featured clinical research presentations.
Log in or Sign up for Free to view tailored content for your specialty!
FDA designates recall of radial artery and arterial line catheterization kits as class I
Arrow International, a subsidiary of Teleflex, has issued a recall of its radial artery and arterial line catheterization kits due to increased resistance that may cause injury to the vessel wall, vasospasm, embolism or death.
FDA approves novel TEER device for treatment of severe tricuspid regurgitation
Abbott announced the FDA approved its novel transcatheter edge-to-edge repair system designed for the treatment of tricuspid regurgitation.
Early-generation TAVR valve shows durable results in high-risk patients at 5 years
Pooled 5-year data of an intra-annular self-expanding transcatheter heart valve in patients with severe aortic stenosis at high surgical risk showed good indicators of durability, researchers reported.
Novel implant for below-the-knee treatment of CLTI gains breakthrough device designation
Elixir Medical announced it received breakthrough device designation FDA for its novel adaptive implant for the treatment of narrowed or blocked below-the-knee vessels in patients with chronic limb-threatening ischemia.
FDA designates recall of left-sided blood pumps as class I
Abiomed has issued a recall of the instructions for use for its left-sided blood pumps, as the pump catheter may perforate the wall of the left ventricle or cause free wall rupture, hypertension, lack of blood flow or death.
Device to treat acute decompensated heart failure feasible, safe in first-in-human study
Among patients with acute decompensated heart failure, device-based thoracic duct decompression demonstrated the ability to reduce congestion safely, according to results of a first-in-human study.
FDA grants breakthrough device designation for resorbable magnesium scaffold for CLTI
Biotronik announced it was granted breakthrough device designation from the FDA its below-the-knee resorbable magnesium scaffold for the treatment of chronic limb-threatening ischemia.
Next-generation TAVR valve linked to less paravalvular leak vs. predecessors
The fifth generation of a balloon-expandable transcatheter aortic valve replacement system was associated with lower rates of paravalvular leak and lower mean gradients compared with predecessor systems, researchers reported.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read